Cisplatin-based combination therapies: Their efficacy with a focus on ginsenosides co-administration
Cisplatin, a frequently prescribed chemotherapeutic agent, serves as a clinically therapeutic strategy for a broad range of malignancies. Its primary mode of action centers around interference with DNA replication and RNA transcription, thereby inducing apoptosis in cancer cells. Nevertheless, the c...
Saved in:
Main Authors: | Keke Li (Author), Jiwen Li (Author), Zhongyu Li (Author), Lei Men (Author), Haibin Zuo (Author), Xiaojie Gong (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of metabolites and metabolism-mediated biological activity assessment of ginsenosides on microfluidic co-culture system
by: Zhongyu Li, et al.
Published: (2023) -
Hematological dynamics following the co-administration of Resveratrol and Cisplatin in Sprague-Dawley rats.
by: Izuchukwu Azuka Okafor, et al.
Published: (2018) -
Antitumor efficacy of EDTA co-treatment with cisplatin in tumor-bearing mice
by: Sabry Ali El-Naggar, et al.
Published: (2020) -
Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prodrug and Curcumin Co-Encapsulated Nanomedicine
by: Hong Y, et al.
Published: (2020) -
Pharmacokinetics and Anti-Tumor Efficacy of PEGylated Liposomes Co-Loaded with Cisplatin and Mifepristone
by: Karen Ocaña-Arakachi, et al.
Published: (2023)